General Information
Revision date
2014-07-01
Product name
revalor-H
Substance name
Implant containing trenbolone acetate and 17β Oestradiol
REACH No
79
1.2.1 Relevant identified uses
Growth promotant and finishing implants for heifers APVMA No 47248 This version issued is valid for 5 years from this date
Icons in SDS
Company Information
company name
known as MSD Animal Health)
Section 2
Hazard statements
This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. Not Hazardous - No criteria found
Precautionary statements
S24/25. Avoid contact with skin and eyes
SUSDP Classification
S5
ADG classification
None allocated. Not a Dangerous Good under the ADG Code
UN Number
None allocated Emergency Overview Physical Description & Colour: Off-white pellets. Odour: No data.
Health hazards
no significant risk factors have been found for this product
Potential health effects
Inhalation: Short Term Exposure: Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short Term Exposure: This product may be mildly irritating to eyes, but is unlikely to cause anything more than mild discomfort which should disappear once product is removed. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. However, this product may be irritating to mucous membranes but is unlikely to cause anything more than transient discomfort. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: 17ß Oestradiol is classified by NTP as reasonably anticipated to be carcinogenic to humans. See the NTP website for further details. A web address has not been provided as addresses frequently change. IARC: No significant ingredient is classified as carcinogenic by IARC.
